Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baloch, Z, P Carayon, B Conte-Devolx, LM Demers, U Feldt-Rasmussen, JF Henry, VA Livosli, P Niccoli-Sire, R John, J Ruf, PP Smyth, CA Spencer, and JR Stockigt. 2003. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3–126.
Baudin, E, CD Cao, AF Cailleux, S Leboulleux, JP Travagli, and M Schlumberger. 2003. Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab 88:1107–1111.
Bellantone, R, CP Lombardi, M Bossola, A Ferrante, P Princi, M Boscherini, L Maussier, M Salvatori, V Rufini, F Reale, L Romano, G Tallini, G Zelano, and A Pontecorvi. 2001. Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study. Cancer 92:2273–2279.
Biscolla, RP, JM Cerutti, and RM Maciel. 2000. Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood. J Clin Endocrinol Metab 85:3623–3627.
Bojunga, J, S Roddiger, M Stanisch, K Kusterer, R Kurek, H Renneberg, S Adams, E Lindhorst, KH Usadel, and PM Schumm-Draeger. 2000. Molecular detection of thyroglobulin mrna transcripts in peripheral blood of patients with thyroid disease by RT-PCR. Br J Cancer 82:1650–1655.
Burmeister, LA, MO Goumaz, CN Mariash, and JH Oppenheimer. 1992. Levothyroxine dose requirements for thyrotropin suppression in the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 75:344–350.
Cailleux, AF, E Baudin, JP Travagli, M Ricard, and M Schlumberger. 2000. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 85:175–178.
Chiovato, L, F Latrofa, LE Braverman, F Pacini, M Capezzone, L Masserini, L Grasso, and A Pinchera. 2003. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 139:346–351.
David, A, A Blotta, M Bondanelli, R Rossi, E Roti, LE Braverman, L Busutti, and EC Degli Uberti. 2001. Serum thyroglobulin concentrations and (131)I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone. J Nucl Med 42:1470–1475.
Denizot, A, C Delfino, A Dutour-Meyer, F Fina, and L Ouafik. 2003. Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer. Thyroid 13:867–872.
Dietlein, M, WA Luyken, H Schicha, and A Larena-Avellaneda. 2005. Incidental multifocal papillary microcarcinomas of the thyroid: is subtotal thyroidectomy combined with radioiodine ablation enough? Nucl Med Commun 26:3–8.
Duren, M, AE Siperstein, W Shen, QY Duh, E Morita, and OH Clark. 1999. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high-and low-risk patients. Surgery 126:13–19.
Elisei, R, A Vivaldi, L Agate, E Molinaro, C Nencetti, L Grasso, A Pinchera, and F Pacini. 2004. Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients. J Clin Endocrinol Metab 89:33–39.
Eustatia-Rutten, CF, JW Smit, JA Romijn, EP Van Der Kleij-Corssmit, AM Pereira, MP Stokkel, and J Kievit. 2004. Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis. Clin Endocrinol (Oxford) 61:61–74.
Feldt-Rasmussen, U, PH Petersen, J Date, and CM Madsen. 1982. Serum thyroglobulin in patients undergoing subtotal thyroidectomy for toxic and nontoxic goiter. J Endocrinol Invest 5:161–164.
Ferrari, L, D Biancolini, E Seregni, G Aliberti, A Martinetti, C Villano, F Pallotti, C Chiesa, and E Bombardieri. 2003. Critical aspects of immunoradiometric thyroglobulin assays. Tumori 89:537–539.
Frasoldati, A, M Pesenti, M Gallo, A Caroggio, D Salvo, and R Valcavi. 2003. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 97:90–96.
Fugazzola, L, A Mihalich, L Persani, N Cerutti, M Reina, M Bonomi, E Ponti, D Mannavola, E Giammona, G Vannucchi, AM Di Blasio, and P Beck-Peccoz. 2002. Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission. J Clin Endocrinol Metab 87:3201–3208.
Haugen, BR, F Pacini, C Reiners, M Schlumberger, PW Ladenson, SI Sherman, DS Cooper, KE Graham, LE Braverman, MC Skarulis, TF Davies, LJ Degroot, EL Mazzaferri, GH Daniels, DS Ross, M Luster, MH Samuels, DV Becker, HR Maxon III, RR Cavalieri, CA Spencer, K Mcellin, BD Weintraub, and EC Ridgway. 1999. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 84:3877–3885.
Haugen, BR, EC Ridgway, BA Mclaughlin, and MT Mcdermott. 2002. Clinical comparison of whole-body radioiodine scan and serum thyroglobulin after stimulation with recombinant human thyrotropin. Thyroid 12:37–43.
Hocevar, M, M Auersperg, and L Stanovnik. 1997. The dynamics of serum thyroglobulin elimination from the body after thyroid surgery. Eur J Surg Oncol 23:208–210.
Iervasi, A, G Iervasi, A Bottoni, G Boni, C Annicchiarico, P Di Cecco, and GC Zucchelli. 2004. Diagnostic performance of a new highly sensitive thyroglobulin immunoassay. J Endocrinol 182:287–294.
Izumi, M, I Kubo,MTaura, S Yamashita, I Morimoto, S Ohtakara, S Okamoto, LF Kumagai, and S Nagataki. 1986. Kinetic study of immunoreactive human thyroglobulin. J Clin Endocrinol Metab 62:410–412.
Lima, N, H Cavaliere, E Tomimori, M Knobel, and G Medeiros-Neto. 2002. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer. J Endocrinol Invest 25:110–115.
Marquet, PY, A Daver, R Sapin, B Bridgi, JP Muratet, DJ Hartmann, F Paolucci, and B Pau. 1996. Highly sensitive immunoradiometric assay for serum thyroglobulin with minimal interference from autoantibodies. Clin Chem 42:258–262.
Mazzaferri, EL, and RT Kloos. 2002. Is diagnostic iodine-131 scanning with recombinant human TSH (rhTSH) useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab 87:1490–1498.
Mazzaferri, EL, RJ Robbins, CA Spencer, LE Braverman, F Pacini, L Wartofsky, BR Haugen, SI Sherman, DS Cooper, GD Braunstein, S Lee, TF Davies, BM Arafah, PW Ladenson, and A Pinchera. 2003. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433–1441.
Morris, LF, AD Waxman, and GD Braunstein. 2002. Interlaboratory comparison of thyroglobulin measurements for patients with recurrent or metastatic differentiated thyroid cancer. Clin Chem 48:1371–1372.
Ozata, M, S Suzuki, T Miyamoto, RT Liu, F Fierro-Renoy, and LJ Degroot. 1994. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 79:98–105.
Pacini, F, M Capezzone, R Elisei, C Ceccarelli, D Taddei, and A Pinchera. 2002. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 87:1499–1501.
Preissner, CM, DJ O’kane, RJ Singh, JC Morris, and SK Grebe. 2003. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab 88:3069–3074.
Randolph, GW, and GH Daniels. 2002. Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid. Thyroid 12:989–996.
Ringel, MD, PW Ladenson, and MA Levine. 1998. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 83:4435–4442.
Robbins, RJ, JT Chon, M Fleisher, S Larson, and RM Tuttle. 2002. Is the serum thyroglobulin response to recombinant human TSH sufficient, by itself, to monitor for residual thyroid carcinoma? J Clin Endocrinol Metab 87:3242–3247.
Robbins, RJ, RM Tuttle, RN Sharaf, SM Larson, HK Robbins, RA Ghossein, A Smith, and WD Drucker. 2001. Preparation by recombinant human thyrotropin or thyroid hormone with drawal are comparable for the detection of residual differentiated thyroid carcinoma. J Clin Endocrinol Metab 86:619–625.
Roelants, V, P De Nayer, A Bouckaert, and C Beckers. 1997. The predictive value of serum thyroglobulin in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 24:722–727.
Spencer, CA. 1996. Recoveries cannot be used to authenticate thyroglobulin (Tg) measurements when sera contain Tg autoantibodies. Clin Chem 42:661–663.
Spencer, CA. 2004. Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. J Clin Endocrinol Metab 89:3702–3704.
Spencer, CA, M Takeuchi, M Kazarosyan, CC Wang, RB Guttler, PA Singer, S Fatemi, JS Lopresti, and JT Nicoloff. 1998. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 83:1121–1127.
Takano, T, A Miyauchi, H Yoshida, Y Hasegawa, K Kuma, and N Amino. 2001. Quantitative measurement of thyroglobulin mrna in peripheral blood of patients after total thyroidectomy. Br J Cancer 85:102–106.
Torlontano, M, M Attard, U Crocetti, S Tumino, R Bruno, G Costante, G D’azzo, D Meringolo, E Ferretti, R Sacco, F Arturi, and S Filetti. 2004. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 89:3402–3407.
Toubeau, M, C Touzery, P Arveux, G Chaplain, G Vaillant, A Berriolo, JM Riedinger, C Boichot, A Cochet, and F Brunotte. 2004. Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer. J Nucl Med 45:988–994.
Van Wyngaarden, K, and IR Mcdougall. 1997. Is serum thyroglobulin a useful marker for thyroid cancer in patients who have not had ablation of residual thyroid tissue? Thyroid 7:343–346.
Wartofsky, L. 2002. Management of low-risk well-differentiated thyroid cancer based only on thyroglobulin measurement after recombinant human thyrotropin. Thyroid 12:583–590.
Wingo, ST, MD Ringel, JS Anderson, AD Patel, YD Lukes, YY Djuh, B Solomon, D Nicholson, PL Balducci-Silano, MA Levine, GL Francis, and RM Tuttle. 1999. Quantitative reverse transcription-PCR measurement of thyroglobulin mRNA in peripheral blood of healthy subjects. Clin Chem 45:785–789.
Wunderlich, G, K Zophel, L Crook, S Smith, BR Smith, and WG Franke. 2001. A high-sensitivity enzyme-linked immunosorbent assay for serum thyroglobulin. Thyroid 11:819–824.
Zophel, K, G Wunderlich, and BR Smith. 2003. Serum thyroglobulin measurements with a high sensitivity enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma? Thyroid 13:861–865.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Mazzaferri, E.L. (2005). Follow-Up of Differentiated Thyroid Cancer Using Serum Thyroglobulin Measurements. In: Amdur, R.J., Mazzaferri, E.L. (eds) Essentials of Thyroid Cancer Management. Springer, Boston, MA. https://doi.org/10.1007/0-387-25714-4_38
Download citation
DOI: https://doi.org/10.1007/0-387-25714-4_38
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25713-6
Online ISBN: 978-0-387-25714-3
eBook Packages: MedicineMedicine (R0)